Pharma Lundensis
SEK0.3170
0
+SEK0.00+0%Friday 09:51
Statistics
Day High
0.317
Day Low
0.317
52W High
1.22
52W Low
0.0414
Volume
1,752,694
Avg. Volume
1,362,316
Mkt Cap
20.38M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-Profit Margin
Unprofitable0Revenue
-7.11MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
PharmaLundensis AB engages in the development of drugs that bind and excrete heavy metals in Sweden. It develops Phal-501 for the treatment of lung diseases COPD and chronic bronchitis. The company was founded in 2006 and is based in Lund, Sweden.
Show More
CEO
Dr. Staffan Skogvall
Employees
2
Country
Sweden
ISIN
SE0003359710
Listings
0 Comments
Share your thoughts
FAQs
What is Pharma Lundensis stock price today?▼
The current price of PHAL.ST is SEK0.32 SEK — it has increased by +0% in the past 24 hours. Watch Pharma Lundensis stock price performance more closely on the chart.
What is Pharma Lundensis stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange Pharma Lundensis stocks are traded under the ticker PHAL.ST.
What is Pharma Lundensis market cap?▼
Today Pharma Lundensis has the market capitalization of 20.38M
What is Pharma Lundensis revenue for the last year?▼
Pharma Lundensis revenue for the last year amounts to 0 SEK.
What is Pharma Lundensis net income for the last year?▼
PHAL.ST net income for the last year is -7.11M SEK.
How many employees does Pharma Lundensis have?▼
As of November 1, 2026, the company has 2 employees.
In which sector is Pharma Lundensis located?▼
Pharma Lundensis operates in the Real Estate sector.
When did Pharma Lundensis complete a stock split?▼
Pharma Lundensis has not had any recent stock splits.
Where is Pharma Lundensis headquartered?▼
Pharma Lundensis is headquartered in Lund, Sweden.